nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—PRLR—Ovarian Infertility Genes—PGR—meningioma	0.101	0.113	CbGpPWpGaD
Fluoxymesterone—PRLR—Nuclear signaling by ERBB4—PGR—meningioma	0.0861	0.0967	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—PDGFB—meningioma	0.04	0.0449	CbGpPWpGaD
Fluoxymesterone—AR—FOXA1 transcription factor network—AP1B1—meningioma	0.0372	0.0418	CbGpPWpGaD
Fluoxymesterone—PRLR—ErbB4 signaling events—ERBB2—meningioma	0.0368	0.0413	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—SMARCE1—meningioma	0.0321	0.036	CbGpPWpGaD
Fluoxymesterone—Dydrogesterone—PGR—meningioma	0.0291	0.265	CrCbGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—PGR—meningioma	0.029	0.0326	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—AP1B1—meningioma	0.0287	0.0322	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—SMARCE1—meningioma	0.0243	0.0273	CbGpPWpGaD
Fluoxymesterone—AR—Nuclear Receptors—PGR—meningioma	0.0214	0.0241	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—AP1B1—meningioma	0.0212	0.0239	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—SMARCE1—meningioma	0.0212	0.0238	CbGpPWpGaD
Fluoxymesterone—Megestrol acetate—PGR—meningioma	0.0175	0.16	CrCbGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—PDGFB—meningioma	0.017	0.019	CbGpPWpGaD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—PGR—meningioma	0.0169	0.019	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptors—PGR—meningioma	0.0165	0.0185	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptors—PGR—meningioma	0.0163	0.0183	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear signaling by ERBB4—PGR—meningioma	0.0162	0.0182	CbGpPWpGaD
Fluoxymesterone—SHBG—Nongenotropic Androgen signaling—AKT1—meningioma	0.0157	0.0176	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—AKT1—meningioma	0.0132	0.0148	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—PGR—meningioma	0.013	0.0146	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—PGR—meningioma	0.0128	0.0144	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—HES1—meningioma	0.0124	0.0139	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—ERBB2—meningioma	0.0114	0.0128	CbGpPWpGaD
Fluoxymesterone—Danazol—PGR—meningioma	0.0113	0.104	CrCbGaD
Fluoxymesterone—PRLR—Immune System—AP1B1—meningioma	0.0113	0.0127	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—PGR—meningioma	0.0109	0.0122	CbGpPWpGaD
Fluoxymesterone—Spironolactone—PGR—meningioma	0.0109	0.0992	CrCbGaD
Fluoxymesterone—Medroxyprogesterone Acetate—PGR—meningioma	0.0102	0.093	CrCbGaD
Fluoxymesterone—Norethindrone—PGR—meningioma	0.0101	0.0921	CrCbGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—PTEN—meningioma	0.00969	0.0109	CbGpPWpGaD
Fluoxymesterone—Betamethasone—PGR—meningioma	0.00925	0.0844	CrCbGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—HES1—meningioma	0.00794	0.00891	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD34—meningioma	0.00767	0.00861	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTSL—meningioma	0.00731	0.00821	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00684	0.00768	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—PLAU—meningioma	0.00659	0.0074	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00614	0.0069	CbGpPWpGaD
Fluoxymesterone—Progesterone—PGR—meningioma	0.00588	0.0537	CrCbGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—PLAU—meningioma	0.00574	0.00645	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—PLAU—meningioma	0.00566	0.00635	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—AKT1—meningioma	0.00558	0.00627	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PGR—meningioma	0.00544	0.00611	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—PGR—meningioma	0.00538	0.0491	CrCbGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CST3—meningioma	0.00527	0.00592	CbGpPWpGaD
Fluoxymesterone—AR—Nongenotropic Androgen signaling—AKT1—meningioma	0.00486	0.00545	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen signaling pathway—AKT1—meningioma	0.00475	0.00534	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HES1—meningioma	0.00473	0.00532	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—SMO—meningioma	0.00473	0.00531	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TSHB—meningioma	0.00461	0.00517	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—meningioma	0.00402	0.00452	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SMO—meningioma	0.00392	0.0044	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PGR—meningioma	0.00376	0.00422	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—ERBB2—meningioma	0.00375	0.00422	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—PTEN—meningioma	0.00362	0.00407	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HES1—meningioma	0.00359	0.00403	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—meningioma	0.00341	0.00383	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PDGFB—meningioma	0.0034	0.00381	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—PTEN—meningioma	0.00338	0.0038	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—PTEN—meningioma	0.00333	0.00374	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PDGFB—meningioma	0.00318	0.00358	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—AKT1—meningioma	0.00299	0.00336	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—PGR—meningioma	0.00292	0.00328	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—AKT1—meningioma	0.00283	0.00317	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	0.00278	0.00313	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HES1—meningioma	0.00257	0.00288	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—PTEN—meningioma	0.00237	0.00267	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—meningioma	0.00231	0.00259	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00231	0.00259	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ERBB2—meningioma	0.00228	0.00256	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—meningioma	0.00227	0.00255	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—PGR—meningioma	0.00225	0.00253	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—meningioma	0.00225	0.00253	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—PGR—meningioma	0.00222	0.00249	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PDGFB—meningioma	0.0022	0.00247	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB2—meningioma	0.00213	0.0024	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—AKT1—meningioma	0.00209	0.00235	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—meningioma	0.002	0.00225	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—AKT1—meningioma	0.002	0.00224	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00197	0.00221	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PTEN—meningioma	0.00194	0.00218	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—AKT1—meningioma	0.00185	0.00207	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—PTEN—meningioma	0.00183	0.00205	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—PTEN—meningioma	0.00182	0.00204	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.00178	0.002	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—meningioma	0.00174	0.00195	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—meningioma	0.00171	0.00192	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—meningioma	0.00169	0.0019	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—meningioma	0.00162	0.00182	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.00152	0.0017	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB2—meningioma	0.00147	0.00165	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PGR—meningioma	0.00141	0.00158	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—AKT1—meningioma	0.00137	0.00154	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00134	0.00151	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PTEN—meningioma	0.00126	0.00141	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—meningioma	0.00125	0.0014	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00113	0.00127	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—AKT1—meningioma	0.00112	0.00126	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PGR—meningioma	0.00108	0.00122	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PGR—meningioma	0.00107	0.0012	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—AKT1—meningioma	0.00105	0.00118	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—AKT1—meningioma	0.00105	0.00118	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.00103	0.00116	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000874	0.000981	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TSHB—meningioma	0.000865	0.000972	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—meningioma	0.000857	0.000962	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SMO—meningioma	0.000736	0.000826	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKT1—meningioma	0.000723	0.000812	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PGR—meningioma	0.000705	0.000792	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HES1—meningioma	0.000482	0.000542	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDGFB—meningioma	0.000412	0.000463	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB2—meningioma	0.000276	0.00031	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—AKT1—meningioma	0.000271	0.000305	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PTEN—meningioma	0.000236	0.000265	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—AKT1—meningioma	0.000209	0.000235	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—AKT1—meningioma	0.000206	0.000231	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—meningioma	0.000161	0.000181	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKT1—meningioma	0.000136	0.000153	CbGpPWpGaD
